Literature DB >> 22865393

National MRSA rates run along with fair play of national football teams: a cross-national data analysis of the European Football Championship, 2008.

E Meyer1, P Gastmeier, F Schwab.   

Abstract

BACKGROUND: We aimed to assess the relationship between national methicillin-resistant Staphylococcus aureus (MRSA) proportions and indicators for fair play in the European Football Championship, 2008. FINDING: We obtained methicillin resistance data for S. aureus from the European Antimicrobial Resistance Surveillance System (EARSS) project. All teams which qualified for the final tournament and had reported data to the EARSS were included in the analysis. Hosting countries were excluded. The number of yellow and red cards was calculated per 100 min as an indicator for fair play. Red cards were weighted like yellow cards. We calculated correlations between antibiotic resistance and use using two-tailed Spearman's coefficient (r) for non-parametric correlations. In 2008, 16 countries qualified for the European Football Championship. Five countries (Turkey, Switzerland, Croatia, Russia and Austria) did not report MRSA data to the EARSS and/or were hosting countries. The correlation of national MRSA proportions and the fair play indicator was highly significant (p = 0.038), with a correlation coefficient of 0.632.
CONCLUSION: This study shows that national MRSA proportions increase with more unfair play of the national teams: Sweden and the Netherlands played the fairest and had the lowest MRSA proportions. However, it remains to be proven (e.g. in the European Football Championship, 2012) whether this fair play indicator, indeed, can serve as an indicator for adherence with MRSA guidelines or whether this correlation cannot be substantiated.

Entities:  

Mesh:

Year:  2012        PMID: 22865393     DOI: 10.1007/s15010-012-0313-y

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  8 in total

1.  Are healthcare economics a factor behind European MRSA rates?

Authors:  M A Borg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-01-30       Impact factor: 3.267

Review 2.  Antibiotic prescribing in hospitals: a social and behavioural scientific approach.

Authors:  Marlies E J L Hulscher; Richard P T M Grol; Jos W M van der Meer
Journal:  Lancet Infect Dis       Date:  2010-03       Impact factor: 25.071

3.  Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.

Authors:  Herman Goossens; Matus Ferech; Robert Vander Stichele; Monique Elseviers
Journal:  Lancet       Date:  2005 Feb 12-18       Impact factor: 79.321

4.  5 years of experience implementing a methicillin-resistant Staphylococcus aureus search and destroy policy at the largest university medical center in the Netherlands.

Authors:  Margreet C Vos; Myra D Behrendt; Damian C Melles; Femke P N Mollema; Woutrinus de Groot; Gerard Parlevliet; Alewijn Ott; Deborah Horst-Kreft; Alex van Belkum; Henri A Verbrugh
Journal:  Infect Control Hosp Epidemiol       Date:  2009-10       Impact factor: 3.254

5.  A qualitative exploration of reasons for poor hand hygiene among hospital workers: lack of positive role models and of convincing evidence that hand hygiene prevents cross-infection.

Authors:  V Erasmus; W Brouwer; E F van Beeck; A Oenema; T J Daha; J H Richardus; M C Vos; J Brug
Journal:  Infect Control Hosp Epidemiol       Date:  2009-05       Impact factor: 3.254

6.  Perceived barriers to guideline adherence: a survey among general practitioners.

Authors:  Marjolein Lugtenberg; Jako S Burgers; Casper F Besters; Dolly Han; Gert P Westert
Journal:  BMC Fam Pract       Date:  2011-09-22       Impact factor: 2.497

Review 7.  Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: a sociocultural perspective.

Authors:  Stephan Harbarth; Werner Albrich; Christian Brun-Buisson
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883

8.  Are cultural dimensions relevant for explaining cross-national differences in antibiotic use in Europe?

Authors:  Reginald Deschepper; Larissa Grigoryan; Cecilia Stålsby Lundborg; Geert Hofstede; Joachim Cohen; Greta Van Der Kelen; Luc Deliens; Flora M Haaijer-Ruskamp
Journal:  BMC Health Serv Res       Date:  2008-06-06       Impact factor: 2.655

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.